© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

MS patients in England to benefit from major roll out of take-at-home pill

Cladribine tablet for those with active multiple sclerosis will reduce hospital visits and free up appointments

Thousands of patients with multiple sclerosis (MS) in England are to become the first in Europe to benefit from a major roll out of an immunotherapy pill.

Current treatments involve regular trips to hospital, drug infusions, frequent injections and extensive monitoring, which add to the burden on patients and healthcare systems.

Continue reading…

Related posts

Family of UK woman with Alzheimer’s vow to stop deportation from Sweden

AEA3

Starmer urges world leaders to ‘double down’ on support for Ukraine

AEA3

Australian Open day two: Stephens v Raducanu, Murray and Kyrgios win – live!

AEA3

Pin It on Pinterest

Share This